Guro L. Goll

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Vaccination of immunosuppressed patients.

Vaccination of immunosuppressed patients.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: April 21, 2026

Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia.

Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia.

Journal: Haematologica
Published: April 09, 2026

Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Journal: RMD open
Published: September 08, 2025

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 13, 2025

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.

Journal: Therapeutic drug monitoring
Published: April 30, 2025

A DNA methylation-based algorithm for diagnosing rheumatoid arthritis.

A DNA methylation-based algorithm for diagnosing rheumatoid arthritis.

Journal: Arthritis research & therapy
Published: March 25, 2025

Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study.

Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study.

Journal: Frontiers in medicine
Published: November 20, 2024

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Journal: RMD open
Published: August 16, 2024

Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease.

Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease.

Journal: Clinical immunology (Orlando, Fla.)
Published: August 14, 2024

Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low-Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial.

Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low-Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 07, 2024

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.

Journal: The Lancet regional health. Europe
Published: August 05, 2024

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.

Journal: EBioMedicine
Published: January 31, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026